Vascular function and multiple sclerosis

Journal of Neurology

Volumn 258, Issue 11, 2011, Pages 2036-2042

  Fjeldstad, Anette S ^a   McDaniel, John ^a   Witman, Melissa A H ^b   Ives, Steve J ^b   Zhao, Jia ^a   Rose, John W ^b,c   Hannon, James ^b   Wray, D Walter ^a,b   Richardson, Russell S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

FMD; Inflammation; Physical activity; Reactive hyperemia

Indexed keywords

C REACTIVE PROTEIN; CATALASE; LIPID HYDROPEROXIDE; SUPEROXIDE DISMUTASE;

ADULT; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BLOOD FLOW VELOCITY; BLOOD LEVEL; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ENZYME ACTIVITY; FEMALE; FERRIC REDUCING ABILITY OF PLASMA; HEMATOLOGICAL PARAMETERS; HUMAN; HYPEREMIA; LIPID PEROXIDATION; MALE; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VENOUS BLOOD; ECHOGRAPHY; INFLAMMATION; MIDDLE AGED; PATHOPHYSIOLOGY; VASODILATATION;

ADULT; BRACHIAL ARTERY; FEMALE; HUMANS; HYPEREMIA; INFLAMMATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; VASODILATION;

EID: 84857666517     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6065-2     Document Type: Article

References (45)

1. Soilu-Hanninen M, Koskinen JO, Laaksonen M, Hanninen A, Lilius EM, Waris M (2005) High sensitivity measurement of CRP and disease progression in multiple sclerosis. Neurology 65:153-155
2. Lilius EM, Rose JW (2006) Antioxidants in multiple sclerosis: do they have a role in therapy? CNS Drugs 20(6):433-441
3. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448-454
4. Del Rincon I, Williams K, Stern M, Freeman GL, O'Leary DH (2003) Escalante A: association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48:1833-1840
5. Duprez DA, Somasundaram PE, Sigurdsson G, Hoke L, Florea N, Cohn JN (2005) Relationship between C-reactive protein and arterial stiffness in an asymptomatic population. J Hum Hypertens 19:515-519
6. Wong M, Toh L, Wilson A, Rowley K, Karschimkus C, Prior D, Romas E, Clemens L, Dragicevic G, Harianto H et al (2003) Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 48:81-89
7. Giovannoni G, Miller DH, Losseff NA, Lewellyn-Smith N, Thompson AJ, Thompson EJ (2001) Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. J Neurol 248:487-495
8. Ortiz GG, Macias-Islas MA, Pacheco-Moises FP, Cruz-Ramos JA, Sustersik S, Barba EA, Aguayo A (2009) Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis. Dis Markers 26(1):35-39
9. Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251(3):261-268
10. Kos D, Kerckhofs E, Nagels G, D'Hooghe MB, Ilsbroukx S (2008) Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 22(1):91-100
11. Smith C, Hale L, Olson K, Schneiders AG (2009) How does exercise influence fatigue in people with multiple sclerosis? Disabil Rehabil 31(9):685-692
12. Motl RW, Arnett PA, Smith MM, Barwick FH, Ahlstrom B, Stover EJ (2008) Worsening of symptoms is associated with lower physical activity levels in individuals with multiple sclerosis. Mult Scler 14(1):140-142
13. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135-1143
14. Timmerman GM, Stuifbergin AK (1999) Eating patterns in women with multiple sclerosis. J Neurosci Nurs 31(3):152-158
15. Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2010) Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 74(13):1041-1047
16. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM (2009) Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120(6):502-509
17. Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney JF Jr, Keyes MJ, Levy D, Vasan RS, Benjamin EJ (2004) Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension 44(2):134-139
18. Harris RA, Nishiyama SK, Wray DW (2010) Richardson RS: ultrasound assessment of flow-mediated dilation. Hypertension 55:1075-1085
19. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111-1115
20. Gokce N, Vita JA, Bader DS, Sherman DL, Hunter LM, Holbrook M, O'Malley C, Keaney JF Jr, Balady GJ (2002) Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am J Cardiol 90(2):124-127
21. Hoidal JR (2001) Reactive oxygen species and cell signaling. Am J Respir Cell Mol Biol 25(6):661-663
22. Knowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298(Pt 2):249-258
23. Gonzalez-Juanatey C, Llorca J, Vazquez-Rodriguez TR, Diaz-Varela N, Garcia-Quiroga H, Gonzalez-Gay MA (2008) Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. Arthritis Rheum 59(12):1821-1824
24. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444-1452
25. Williams MR, Westerman RA, Kingwell BA, Paige J, Blombery PA, Sudhir K, Komesaroff PA (2001) Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 86(11):5389-5395
26. Richardson RS, Donato AJ, Uberoi A, Wray DW, Lawrenson L, Nishiyama S, Bailey DM (2007) Exercise-induced brachial artery vasodilation: role of free radicals. Am J Physiol Heart Circ Physiol 292(3):H1516-H1522
27. Pyke KE, Tschakovsky ME (2005) The relationship between shear stress and flow-mediated dilation: implications for the assessment of endothelial function. J Physiol 568:357-369
28. Fukuzawa K, Shibata A, Okamura C, Fujiwara Y, Akai K, Tsuchiya K, Tokumura A, Gebicki JM (2009) Measurement of lipid hydroperoxides by the ferric-xylenol orange method (1) characteristics of the ferric-xylenol orange/membrane phosphatidylcholine complex. J Nutr Sci Vitaminol (Tokyo) 55(1):9-14
29. Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239(1):70-76
30. Freedson PS, Melanson E, Sirard J (1998) Calibration of the computer science and applications, Inc. accelerometer. Med Sci Sports Exerc 30(5):777-781
31. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW (1995) A health-related quality of life measure for multiple sclerosis. Qual Life Res 4(3):187-206
32. Uehata A, Lieberman EH, Gerhard MD, Anderson TJ, Ganz P, Polak JF, Creager MA, Yeung AC (1997) Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery. Vasc Med 2(2):87-92
33. Khurana SR, Bamer AM, Turner AP, Wadhwani RV, Bowen JD, Leipertz SL, Haselkorn JK (2009) The prevalence of overweight and obesity in veterans with multiple sclerosis. Am J Phys Med Rehabil 88(2):83-91
34. Van Doornum S, McColl G, Jenkins A, Green DJ, Wicks IP (2003) Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 48(1):72-80
35. Moro L, Pedone C, Scarlata S, Malafarina V, Fimognari F, Antonelli-Incalzi R (2008) Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology 59(3):357-364
36. Loscalzo J, Vita JA (1994) Ischemia, hyperemia, exercise, and nitric oxide. Complex physiology and complex molecular adaptations. Circulation 90(5):2556-2559
37. Huang AL, Silver AE, Shvenke E, Schopfer DW, Jahangir E, Titas MA, Shpilman A, Menzoian JO, Watkins MT, Raffetto JD et al (2007) Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 27(10):2113-2119
38. Karg E, Klivenyi P, Nemeth I, Bencsik K, Pinter S, Vecsei L (1999) Nonenzymatic antioxidants of blood in multiple sclerosis. J Neurol 246(7):533-539
39. Crayton H, Heyman RA, Rossman HS (2004) A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 63(11 Suppl 5):S12-S18
40. Motl RW, McAuley E, Snook EM (2005) Physical activity and multiple sclerosis: a meta-analysis. Mult Scler 11(4):459-463
41. Bencsik K, Rajda C, Fuvesi J, Klivenyi P, Jardanhazy T, Torok M, Vecsei L (2001) The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrad County, Hungary. Eur Neurol 46(4):206-209
42. Turner AP, Kivlahan DR, Haselkorn JK (2009) Exercise and quality of life among people with multiple sclerosis: looking beyond physical functioning to mental health and participation in life. Arch Phys Med Rehabil 90(3):420-428
43. Mostert S, Kesselring J (2002) Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 8:161-168
44. Schapiro RT (2005) Managing symptoms of multiple sclerosis. Neurol Clin 23(1):177-187 (vii)
45. Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F, Giusti C, Salvetti A (2000) Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 25:2896-2901